The invention relates to substituted indazoles, to the use thereof, alone or in combinations, for the treatment and/or prophylaxis of autoimmune diseases, and to the use thereof for producing prescription drugs for the treatment and/or prophylaxis of autoimmune diseases, in particular for the treatment and/or prophylaxis of forms of arthritis (in particular psoriatic arthritis, rheumatoid arthritis, ankylosing spondylitis, reactive arthritis, systemic juvenile idiopathic arthritis), systemic lupus erythematosus, multiple sclerosis, psoriasis, atopic dermatitis, allergic eczema, and chronic inflammatory intestinal diseases (in particular Crohn's disease and ulcerative colitis).
